Estrella Immunopharma Warrant
ESLAW
10 hedge funds and large institutions have $262K invested in Estrella Immunopharma Warrant in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.08% less ownership
Funds ownership: 2.1% → 2.02% (-0.08%)
9% less funds holding
Funds holding: 11 → 10 (-1)
14% less capital invested
Capital invested by funds: $306K → $262K (-$44K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$380 |
| 2 |
CS
Clear Street
New York
|
+$9 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Trading
New York
|
-$1.72K |
| 2 |
Walleye Capital
New York
|
-$908 |
| 3 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$299 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFM
1
Boothbay Fund Management
New York
| $176K | – | – | – |
|
|
HCM
2
Highbridge Capital Management
New York
| $40.6K | – | – | – |
|
|
ASM
3
ATW SPAC Management
New York
| $16.2K | – | – | – |
|
4
D.E. Shaw & Co
New York
| $6.74K | – | – | – |
|
|
SIA
5
SkyView Investment Advisors
Shrewsbury,
New Jersey
| $6K | – | – | – |
|
|
6
Walleye Trading
New York
| $5.61K | -$1.72K | -20,136 | -22% |
|
|
YCM
7
Yakira Capital Management
Westport,
Connecticut
| $4.11K | – | – | – |
|
|
WA
8
Whitebox Advisors
Minneapolis,
Minnesota
| $3.26K | – | – | – |
|
|
CS
9
Clear Street
New York
| $2.21K | +$9 | +100 | +0.3% |
|
|
LCM
10
Landscape Capital Management
Englewood,
New Jersey
| $1.05K | – | – | – |
|
|
11
UBS Group
Zurich,
Switzerland
| $343 | +$380 | +4,453 | New |
|
|
12
Walleye Capital
New York
| – | -$908 | -10,330 | Closed |
|
|
WAM
13
Wolverine Asset Management
Chicago,
Illinois
| – | -$299 | -3,256 | Closed |
|
ESLAW Hedge Fund Activity: Q1 2025 in Review
10 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Estrella Immunopharma Warrant (ESLAW) for Q1 2025, worth a combined $262K — down 14% from $306K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ESLAW and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, opening a new position worth an estimated $380. The largest seller was Walleye Trading, cutting an estimated $1.72K.
- 10 institutional investors held Estrella Immunopharma Warrant (ESLAW) as of Q1 2025, down from 11 in Q4 2024.
- Funds reported $262K of Estrella Immunopharma Warrant stock for Q1 2025, down 14% quarter-over-quarter.
- 1 fund opened new Estrella Immunopharma Warrant positions in Q1 2025 and 2 closed out, a net change of -1 holder.
- The largest Estrella Immunopharma Warrant buyer in Q1 2025 was UBS Group, an estimated $380 added.
- The largest Estrella Immunopharma Warrant seller in Q1 2025 was Walleye Trading, an estimated $1.72K sold.
Based on aggregated 13F filings for Q1 2025.